Evidence map›Paper›PMID 41250041›Full record

Observational studyBMC public health2025

Transition from HIV post-exposure prophylaxis to pre-exposure prophylaxis and awareness-to-use cascade among men who have sex with men: a longitudinal study in Guangxi, China.

Yun Zhang, Min Wang, Jinli Mo, Weiyi Tian, Haimei Huang, Jiawen Zhu, Sumin Tan, Yingqiong Huang, Li Jiang, Ping Cen and 5 more

Abstract readObservational Study
In one paragraph

Observational study in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yun Zhang *Nursing College, Guangxi Medical University, Nanning, Guangxi, China.ORCID http://orcid.org/0000-0002-7675-9932
Min Wang *The Second Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, China.
Jinli MoThe Second Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, China.
Weiyi TianNursing College, Guangxi Medical University, Nanning, Guangxi, China.
Haimei HuangThe Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Jiawen ZhuThe Second Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, China.
Sumin TanThe Second Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, China.
Yingqiong HuangNursing College, Guangxi Medical University, Nanning, Guangxi, China.
Li JiangNursing College, Guangxi Medical University, Nanning, Guangxi, China.
Ping CenNanning Municipal Center for Disease Prevention and Control, Nanning, Guangxi, China.
Guanghua LanInstitute of HIV/AIDS Prevention and Control, Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning, Guangxi, China.
Jieling MoNursing College, Guangxi Medical University, Nanning, Guangxi, China.
Lili ShiThe Second Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, China.
Hao WangNursing College, Guangxi Medical University, Nanning, Guangxi, China.
Chuanyi NingNursing College, Guangxi Medical University, Nanning, Guangxi, China. ningchuanyi@126.com.ORCID http://orcid.org/0000-0002-8748-2780

Funding

the General Program of the Natural Science Foundation of Guangxi in China 2023GXNSFAA026287the Guangxi Key Laboratory of Major Infectious Disease Prevention and Control and Biosafety Emergency Response GKLKP-KF-202202the Guangxi Key Research and Development Project Guike AB24010175The Outstanding Youth Fund of The Natural Science Foundation of Guangxi in China 2023GXNSFFA026007the Self-funded Scientific Research Project by the Health Commission of Guangxi Zhuang Autonomous Region Z-A20240621
6 · The paper itself

Abstract

backgroundHIV post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) are effective yet underutilized HIV prevention modalities. This study aims to evaluate the awareness-to-use cascade for PEP and PrEP, and to examine the transition from PEP to PrEP among men who have sex with men (MSM). We will discuss the rationale for using PrEP after PEP use.

methodsWith an observational, longitudinal study design, MSM were recruited from five cities in Guangxi, China. Participants completed questionnaires every 3 months and were tracked for 12 months. Descriptive statistics summarized the awareness, use, cascade and transition of PEP and PrEP. The effect of PEP use on PrEP use was analyzed using Generalized Estimating Equations.

resultsA total of 363 eligible MSM were recruited, and 350 participants completed at least one follow-up visit. Overall, at baseline, 96.7% were aware of PEP, and 15.2% used it. 76.0% were aware of PrEP, and 5.2% used it. According to baseline and follow-up surveys, of the 68 participants who used PEP, 29.4% reported initiating PrEP after a PEP course; of these, 60.0% did so after a single course. The median number of PEP uses before transitioning was 1 (interquartile range [IQR]: 1 to 2.5). The median time interval for transitioning from PEP to PrEP was 11 months (IQR: 4 to 18 months). After adjusting for sociodemographic and sexual behavior factors, having previously used PEP is one of the main predictors of PrEP use (adjusted odds ratio [AOR] 5.45, 95% CI: 1.80-16.50).

conclusionsAlthough awareness of PEP and PrEP among MSM in Guangxi, China was high, the proportion of participants initiating PEP and PrEP remained low. It is recommended that effective support and screening for transitioning to PrEP be provided after a successful first use of PEP to promote the broader implementation of HIV prevention measures.

Indexed as

Health Knowledge, Attitudes, PracticeHIV InfectionsHomosexuality, MalePost-Exposure ProphylaxisPre-Exposure ProphylaxisAdultChinaHumansLongitudinal StudiesMaleMiddle AgedSurveys and QuestionnairesYoung AdultCascadeHIV preventionMen who have sex with menPost-exposure prophylaxisPre-exposure prophylaxisTransition

Identifiers

PMID41250041
PMCPMC12625293

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.